Sekisui Diagnostics LLC

One Wall Street, 01803 Burlington, MA
USA
info@sekisui-dx.com

Sekisui Diagnostics

Product Categories

Product categories

03 Diagnostic Tests
03.01 Clinical chemistry
03.01.04 Rapid tests in clinical chemistry

Rapid tests in clinical chemistry

ACETAMINOPHEN-L3K®
AMYLASE, DIRECT
ASPARTATE AMINOTRANSFERASE (AST/SGOT)-SL

03 Diagnostic Tests
03.01 Clinical chemistry
03.01.05 Other equipment for clinical chemistry

Other equipment for clinical chemistry

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.01 Immuno assay testing

Immuno assay testing

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.02 Diagnostic rapid tests

Diagnostic rapid tests
Our products

Product category: Rapid tests in clinical chemistry
ACETAMINOPHEN-L3K®
Acetaminophen (paracetamol) is used as an analgesic in many different formulations. While therapeutic doses rarely cause adverse side effects, the effect of long term treatment with acetaminophen is unclear. Cases have been reported where chronic excessive use of acetaminophen has led to hepatotoxicity and nephrotoxicity. In cases of acute overdosage, acetaminophen can cause severe hepatic damage leading to hepatic failure if untreated.

ACETAMINOPHEN-L3K®

For the quantitative measurement of acetaminophen.
Two part stable liquid. Easy to use, no additional reagent preparation required.
A single level liquid acetaminophen calibrator is included in the kit. Convenient and cost effective.
Reduced NAC interference. Confidence in results.
Suitable for use with serum and lithium heparin plasma. Flexible sample types to meet different laboratory needs.
Calibrator included in the kit
Product Availability: Americas, Europe, Contact Us

Product category: Rapid tests in clinical chemistry
AMYLASE, DIRECT
For many years, the levels of serum and plasma amylase in patients have provided needed evidence for the diagnosis of acute pancreatitis. Early assay techniques were based on either a change in the absorption maxima of the complex between starch and iodine as the amylase degraded the starch; or a measurement of the increase in reducing groups as the starch was hydrolyzed by the amylase. These methods are not as reliable and easy to quantitate as spectrophotometric methods using a defined substrate.

AMYLASE, DIRECT

For the quantitative measurement of amylase (a1, 4-glucan-4-glucanohydrolase, E.C.3.2.1.1) activity in serum and plasma.
One part, stable liquid; ready to use reagent. Easy to use, no additional reagent preparation required.
Short reaction time with no lag phase. Faster throughput on automated analyzers.
Excellent precision. Confidence in results.
No significant interferences from triglyceride, glucose, ascorbic acid, bilirubin or hemoglobin. High reliability of testing and fewer re-tests.
Product Availability: Americas, Contact Us

Product category: Rapid tests in clinical chemistry
ASPARTATE AMINOTRANSFERASE (AST/SGOT)-SL
Elevated concentrations of aspartate aminotransferase result from a myocardial infarction, or hepatic disease. In cases of hepatic necrosis, elevations of AST concentrations occur prior to the onset of clinical symptoms such as jaundice. To a lesser extent elevated concentrations are indicative of diseases of some internal organs.

ASPARTATE AMINOTRANSFERASE (AST/SGOT)-SL

For the quantitative measurement of aspartate aminotransferase.
Can be run as a two part or single part reagent system. Easy to use; no additional reagent preparation required.
Wide variety of chemistry analyzer applications available. Flexible testing
Calibrator: DC-Cal Multi-Analyte Calibrator

Control: DC-Trol Multi-Analyte Control Materials

Product Availability: Americas, Europe, Contact Us

ad: contact information

About Us

Company details
YOUR GLOBAL DIAGNOSTICS PARTNER

Sekisui Diagnostics is part of the Sekisui Chemical Co. Ltd. family, and a sister company to Sekisui Medical. Backed by the resources of our global parent, we remain focused on contributing to the realization of healthy and enriched lifestyles for all people.

Headquartered in Burlington, MA, USA, Sekisui Diagnostics has annual revenue of $200 million and more than 450 employees worldwide. Our R&D and manufacturing facilities are located internationally on two different continents while our long tenured sales & service staff concentrates on building strong partnerships with our customers across the globe.

Global Reach, Regional Focus

In recent years, social and consumer needs for medical care have been diversifying in line with dramatic transformations in the global medical environment. We will continue to embrace change and challenge new frontiers so that we can create unique, high-quality products and services that will leave our customers truly satisfied. With worldwide state-of-the-art manufacturing facilities and an international sales and distribution network, we are a solid partner for healthcare professionals, distributors, and manufacturers around the world. Our global capabilities allow us to meet the specific needs of our wide range of customers – and customize solutions at both a regional and product level.

ad: company

ScottCare Cardiovascular Solutions
SDIX, LLC
Seal Shield
Sensus Healthcare
SEPLOU Medical, Inc.
SeraCare Life Sciences, Inc.
Seal Shield
SDIX, LLC
ScottCare Cardiovascular Solutions
Scapa Healthcare PLC
Scantibodies Laboratory, Inc.

Sensus Healthcare
SEPLOU Medical, Inc.
SeraCare Life Sciences, Inc.
Shamrock Marketing Co., Inc.
Sharn, Inc.